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Effect of membrane filtration of antimalarial drug
solutions on in vitro activity against Plasmodium
falciparum *
J. K. BAIRD1 & C. LAMBROS2
Antimalarial activities ofchloroquine, mefloquine, amodiaquine, and quinine in vitro
against Plasmodium falciparum were diminished as a consequence ofmembranefiltration.
Filtered drug solutions gave IDso values up to 25-fold greater than those of non-filtered
(ethanol-sterilized) drug solutions. Loss ofactivity byfiltration was overcome by increasing
the drug concentration prior to filtration. Water solutionsfiltered through Millex-GSfilter
units consistently showed an absorbance maximum at 277 nm, accompanied by a lesser
peak at 225 nm. Water filtrates from Nucleopore and Millex-G Vfilters showed no absor-
bance at 277 nm and only slight absorbance was evidentfor the Gelmanfilter unit. Activity
losses were attributed to extractable contaminating moieties in the membranefilters and/or
drug binding to the membrane filters.
Sterile disposable filter units are widely used for the
sterilization of tissue culture media components and
drug solutions in various analytical and biological
testing procedures. A recent survey of major medical
centres in the United States revealed that, although a
high proportion (36%) of their clinical laboratories
use membrane filtration to sterilize drug solutions for
use in quantitative susceptibility tests, none had deter-
mined whether membrane filtration had affected
drug activity (1). While Murray & Niles (2) obtained
full recovery of antimicrobial activity following fil-
tration of solutions containing 1000 and 100 mg/l of
the drug, inhibitory effects of membrane-sterilization
of solutions have been reported in mammalian (3, 4),
protozoan (5), bacterial (6), and viral (7) culture
systems.
Because antimalarial drug solutions are routinely
sterilized by membrane filtration for in vitro drug
testing procedures, we have examined the effects of
filtration on the activities of some standard anti-
malarials against Plasmodium falciparum in an in
vitro susceptibility test system. The results show cause
for careful interpretation of drug sensitivity studies.
* From the Division of Experimental Therapeutics, Walter Reed
Army Institute of Research, Washington, DC 20307, USA. The views
expressed here are those of the authors alone and not of the Depart-
ment of the Army or the Department of Defense. Requests for re-
prints should be sent to Dr J. K. Baird.
Research Associate.
2 Research Parasitologist.
MATERIALS AND METHODS
Filter membranes
Four different filter membranes were tested: Gel-
man Acrodisca (esters of cellulose acetate), 25 mm2
and 0.2 jim pore size; Nucleopore filter discb (poly-
carbonate), 25 mm2 and 1.0 Am pore size; Millex-GV
filter unitc (fluorocarbon), 25 mm2 and 0.22 ,um pore
size; and Millex-GS filter unitC (mixed esters of cellu-
lose acetate), 25 mm2 and 0.22 1tm pore size.
Drugs
Chloroquine diphosphate, mefloquine hydro-
chloride, amodiaquine hydrochloride, and quinine
sulfate were obtained from the US Army Anti-
malarial Drug Development Program Inventory in
powder form.
Biological activity
The multidrug-resistant Viet Nam Smith strain of
P.falciparum (8) was used as test organism. Cultures
were maintained in human A+ red cells in culture
medium RPMI 1640d supplemented with HEPES
buffer and 10%o human A+ plasma (9-11). Anti-
a Gelman Sciences Inc., Ann Arbor, MI, USA.
b Nucleopore Corp., Pleasanton, CA, USA.
c Millipore Corp., Bedford, MA, USA.
d Gibco Laboratories, Grand Island, NY, USA.
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malarial activity was measured as previously de-
scribed (9, 10) using 96-well microtitration plates.
Inhibition of incorporation of [G_3HJ-hypoxanthinee
by the parasites served as an index of antimalarial
activity. The drugs were initially dissolved in 70%
ethanol to a concentration of 1000 mg/l and sub-
sequent dilutions were made with the culture medium.
Membrane filtration of the drug solutions is not re-
quired for sterilization in this test system.
To determine the effect of filtration on antimalarial
activity, stock solutions of the drugs were prepared in
70%Yo ethanol to an initial concentration of 2000 mg/l
and then diluted further in distilled water to a final
concentration of 2 mg/l. Ten millilitres of the 2 mg/l
drug solution were then filtered through each of four
filter types. Each filtrate was then serially diluted
2-fold with culture medium in the microtitration
plates.
The data were analysed by nonlinear regression
analysis (9, 10) to obtain the 50% inhibitory dose
(ID5o), i.e., the drug concentration corresponding to
500o inhibition of the uptake of radiolabelled hypo-
xanthine by the parasites.
Ultraviolet absorbance spectrophotometry of water
filtrates
Nucleopore membranes were not housed in dis-
posable units but were placed into sterilized stainless
steel filter housings for fitting to syringes. The mem-
branes, handled with stainless steel forceps at all
times, were sterilized by autoclave (120 °C, 1.4 kg/
cm2 for 15 minutes) and dried at 25 °C prior to use.
Each individual membrane was fitted to a 10-ml
plastic syringe, and 3 ml of sterile, distilled and de-
ionized water were passed through the filter unit. The
filtrate was immediately dispensed into a quartz
cuvette and an absorbance profile was obtained for
the 200-350 nm range in a Varian-Cary model 219
spectrophotometer! Possible contributions by other
items of the apparatus were checked by repetition of
the technique with the membranes omitted.
Spectrophotometric measurement of drugs and drug
filtrates
Drug losses due to filtration were quantified as
follows. Chloroquine, mefloquine, amodiaquine and
quinine were made at a concentration of 2000 mg/l in
70%o ethanol. Subsequent dilutions were made with
sterile distilled and deionized water to a final concen-
tration of 2.0 mg/l; 10.0 ml of each solution were
passed through each filter type. Absorbancy before
and after filtration was measured at the optimal
wavelengths for each drug (chloroquine, 343 nm;
New England Nuclear, Boston, MA, USA.
Varian Associates Inc., Palo Alto, CA, USA.
mefloquine, 310 nm; amodiaquine, 340 nm; and
quinine, 330 nm). The percentage drug loss due to fil-
tration was calcuated using the equation:
absorbance after
% drug loss = 100- filtration x 100
absorbance before
ChoounL filtration
Chloroquine in solution is known to obey Beer's
law (12). We also observed a linear relationship be-
tween UV light absorbance and drug concentration
for mefloquine, amodiaquine, and quinine at their re-
spective wavelengths of absorbance measurement.
RESU LTS
The biological activity of the antimalarials after
their filtration through the individual filter types is
summarized in Table 1. Decreased antimalarial ac-
tivity was most evident with amodiaquine regardless
of the filter types used, whereas quinine had the least
deviation from the ethanol-sterilized standard ac-
tivity. All compounds showed marked binding to the
Millex-GV membranes (67-980/o).
The results on the antimalarial activities of chloro-
quine and mefloquine solutions filtered through
Millex-GV filter units at two different concentrations
are given in Table 2. Solutions filtered at a concen-
tration of 2000 mg/l gave ID50 values comparable to
those of nonfiltered drug solutions whereas those
1.0
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Fig. 1. UV spectra: TEST, water passed through a
Millex-GS filter unit; CONTROL, water passed through a
plastic syringe with membrane omitted; BASELINE,
untreated water.
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Table 1. ID50 values of
against P. falciparum
non-filtered and filtered solutions of chloroquine, mefloquine, amodiaquine and quinine
ID50 (mg/1)a
Drug filter % drug boundb Observedc Correctedc Fold increase
Chloroquine:
Ethanol - 54.0 54.0 (1.7) 1.0
Nucleopore 2 > 145.0 > 196.0 > 2.0
Gelman 5 98.0 95.0 (8.3) 1.7
Millex-GV 75 > 200.0 > 50.0 > 0.92
Millex-GS,d 22 > 150.0 > 176.0 > 2.4
Millex-GS2d 22 120.0 110.0 13.9) 2.0
Mefloquine:
Ethanol - 1.5 1.5 (0.27) 1.0
Nucleopore 0 4.2 4.2 (0.51) 2.8
Gelman 11 4.0 3.7 (0.19) 2.5
Millex-GV 87 38.0 4.6 (0.42) 3.1
Millex-GS, NDf 4.0 ND
Millex-GS2 NDf 3.7 ND
Amodiaquine:
Ethanol _ 7.6 7.6 (1.68) 1.0
Nucleopore 2 > 56.0 > 49.0 > 3.9
Gelman 7 > 56.0 > 47.0 > 6.1
Millex-GV 98 > 56.0 _e -
Millex-GS, 12 > 56.0 > 44.0 > 5.8
Millex-GS2 12 > 56.0 > 44.0 > 2.0
Quinine:
Ethanol - 54.0 54.0 (5.5) 1.0
Nucleopore 0 72.0 72.0 (0.69) 1.3
Gelman 4 120.0 113.0 (4.1) 2.0
Millex-GV 67 140.0 59.0 (3.3) 1.1
Millex-GS, 10 120.0 106.0 (2.9) 1.9
Millex-GS2 10 58.0 55.0 (5.6) 1.0
a Values of ID5o are the average of four determinations performed on separate occasions. Numbers in parentheses are the standard
error of the nonlinear regression analysis (17).
b For calculation, see pp. 439-440 (Materials and Methods).
Observed 1D5o was adjusted by multiplying the percentage drug bound by the observed ID50 and subtracting the product from the
observed ID5o to give the corrected value.
d Millex-GS, was taken from a lot known to contain a relatively high concentration of contamination as determined by filtrate
absorbance at 277 nm (0.5, see Fig. 1). Millex-GS2 was taken from a lot known to contain a relatively low concentration of con-
tamination (0.05, see Fig. 1).
e Out of the test range, owing to the high degree of drug binding to the filter membrane.
f Owing to spectral interference from the Millex-GS contaminant (A277), spectrophotometric determination of mefloquine (A310)
loss to these filters was not done. Thus, no data may be given for the corrected ID50 and fold increase for this drug passed through
these filters.
filtered at 10 mg/l showed appreciable reductions in
activity.
Evidence that a contaminating moiety is extracted
when water solutions are filtered through Millex-GS
filter units is shown in Fig. 1. In several filtrates of dis-
tilled water (or physiological saline, data not shown)
an absorbance maximum at 277 nm was always evi-
dent, accompanied by a lesser peak at 225 nm.
Absorbances at 277 nm in water filtrates from
several lots of Millipore's GS type membranes (filter
discs and filter units) as well as from several samples
of Gelman, Nucleopore and Millex-GV filters are
summarized in Table 1. No absorbance was con-
tributed by the Nucleopore and Millex-GV filters, and
only slight absorbance was evident in the Gelman
filter unit filtrates.
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Table 2. Antimalarial activity of Millex-GV filtered and
non-filtered solutions of chloroquine and mefloquine
solutions against P. falciparum
Filtered solutions
Drug (mg/I) ID50 (,g/l)
Chloroquine not filtered 51.0 (3.7 a
10 124.0 (4.8)
2000 59.0 (5.3)
Mefloquine not filtered 1.7 (0.36)
10 28.0 (2.7)
2000 1.0 (0.31)
Values are the average of duplicate determinations per-
formed on two separate occasions. Numbers in parentheses are
the standard error of the nonlinear regression analysis (based
on information in a pamphlet describing nonlinear regression
analyses and computer programming by D. Rodbard, Biomedical
Computing Technology Information Center, Nashville, Ten-
nessee, 1980).
DISCUSSION
The effects of membrane filtration on antimalarial
drug solutions and their subsequent activities in vitro
have been shown in this study. Drug solutions, when
filtered at low concentrations through different types
of membrane filter units, may lose their activity in
vitro against Plasmodium falciparum. We attribute
the losses in antimalarial activity to at least two
factors: (a) drug binding to membrane filters and
(b) materials extractable from the membranes into
the drug solution filtrates.
The highest percentage of drug binding was evi-
denced with the Millex-GV filter unit, ranging from
6707o for quinine to 98%o for amodiaquine, which was
reflected in the observed ID50 values for the anti-
malarials tested (see Table 1). In addition, the data
from Table 2 indicate that filtration of chloroquine
or mefloquine solutions at high concentration (2000
mg/l) through Millex-GV filters did not affect drug
activity; filtration at low concentration (10 mg/l)
affected activity appreciably. This suggests that
solutions at high concentration may have over-
whelmed the capacity of the membrane filters to bind
the drug, which may have otherwise influenced the
antimalarial activity.
Binding of the drug to the filter, however, does not
account for all loss of activity. This is most evident in
the results obtained with the Nucleopore and Gelman
filters (Table 1). Although these filters showed
< II 1o binding of the drug, the diminution in drug
activity was consistently in excess of that expected at
such levels of drug-filter binding. Most membrane
filters contain nonionic detergents, such as Triton X-
100 (which may comprise 2-3% of their dry weight) to
improve fluid flow (13). These detergents or other
materials present in the membrane may be extracted
during the filtration process and appear in the fil-
trates. Technical information provided by manufac-
turers do not mention this possibility. An absorbance
maximum in the ultraviolet light wavelength region of
275 to 277 nm was found by Rosenbluth & Cripps
(14) in both water filtrates from cellulose-based filter
media and in a nonfiltered aqueous solution of iso-
octyl-phenoxy-polyethoxy-ethanol (IPPE, Triton X-
100). By measuring the ultraviolet light absorbance
of water filtrates from both cellulose and poly-
carbonate filter media, Cooney (15) detected appreci-
able amounts of contaminant(s). In our study the
presence of a contaminant with an absorbance maxi-
mum at 277 nm was demonstrated in water filtrates of
Millipore-GS type filters (Fig. 1, Table 3); absorb-
ancy at this wavelength was not detected in filtrates
from fluorocarbon or polycarbonate membranes. We
suggest that materials extracted from these filter units
into the drug filtrates, which are not necessarily de-
tectable by ultraviolet spectroscopy, may antagonize
in vitro the antiplasmodial activity of the standard
drugs tested. It may not be stated with certainty that
the contaminating moieties characterized by UV light
absorbance at 277 nm were directly responsible for
activity diminution.
In summary, our study indicates that filtration of
antimalarial drug solutions at low concentrations
Table 3. Absorbance at 277 nm of distilled water fil-
trates; a volume of 3.0 ml was passed through each
filter unit
Filter type Absorbance at 277 nm
Millipore-GS C1H1 1116a 0.036 (0.0025)b
C1H09169 0.060 (0.005)
C8P80362 0.067 (0.003)
C8N75415 0.229 (0.015)
C8N78264 0.373 (0.030)
Gelman
Acrodisc' 0.017 (0.004)
Nucleopore
disc' 0.000 -
Millex-GV
unit' 0.000 -
e Code following Millipore-GS tests denote manufacturer's lot
numbers.
Numbers in parentheses are the standard error of 5 to 10
determinations.
c At least three different manufacturer's lot numbers were
sampled and 3 to 5 filters from each lot were examined.
442
MEMBRANE FILTRATION OF ANTIMALARIAL DRUG SOLUTIONS
results in losses of drug activity as a consequence of
chemical impurities and/or drug loss from solution
during filtration. To prevent erroneous reporting of
drug susceptibility studies, we strongly recommend
that drug solutions be filtered at high concentration
followed by aseptic serial dilution of the filtrate. This
practice would minimize the percentage drug loss to
the filter apparatus and dilute out any extracted con-
taminants if present. Another possibility may be the
initial dissolution of the drug in ethanol with sub-
sequent serial dilutions performed aseptically. A
similar statement of caution has been expressed by
Geary et al. (16) concerning chloroquine binding to
glass and cellulose acetate filters.
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RESUME
MODIFICATION DE L'ACTIVITE IN VITRO DES ANTIPALUDEENS
FILTRES SUR MEMBRANE VIS-A-VIS DE PLASMODIUMFALCIPARUM
Les unites de filtration sterile A usage unique sont large-
ment utilisees dans differentes epreuves biologiques et
methodes analytiques pour la sterilisation des differents
composants des milieux de culture tissulaire et celle des solu-
tions de medicaments. De nombreux laboratoires cliniques
ont recours A la filtration sur membrane pour steriliser les
solutions de medicaments destinees A des epreuves quantita-
tives de sensibilite; aucun cependant n'a etabli si ce mode de
filtration avait modifie l'activite du medicament. On a dejA
signale un effet inhibiteur de ce procede de sterilisation des
solutions sur les cultures de cellules mammaliennes et celles
de protozoaires, de bacteries et de virus. Vu que les solutions
d'antipaludeens sont couramment sterilisees par filtration
sur membrane en vue des essais in vitro des medicaments,
1'effet de la filtration des antipaludeens a usage clinique et
leur activite sur Plasmodiumfalciparum apres filtration ont
et etudies dans une epreuve de sensibilite in vitro.
Quatre membranes filtrantes ont et mises A l'essai: Gel-
man Acrodisc (desacetate de cellulose), disque filtrant
Nucleopore (polycarbonate), Millex-GV (fluorocarbone) et
Millex-GS (melange d'esters cellulosiques). La chloroquine
(sous forme de diphosphate), la mefloquine, I'amodiaquine
(chlorhydrate) et la quinine (sulfate) ont et obtenues en
poudre aupres de l'U.S. Army Antimalarial Drug Develop-
ment Program. La souche Smith de P.falciparum a et
utilisee pour mesurer l'activite biologique. Les cultures ont
e entretenues au moyen de la methode de Trager-Jensen.
Comme indicateur de l'activite antipaludique, on a utilise
l'inhibition de l'incorporation d'hypoxanthine tritiee [G-
3H] par le parasite; dans cette methode de mesure, les solu-
tions de produits n'ont pas besoin d'etre filtrees sur mem-
brane. Afin de preciser l'influence de la filtration sur l'ac-
tivite antipaludique, 10 ml d'une solution de medicament A
2 mg/l ont et filtres sur chacune des unites de filtration. Les
resultats ont et analyses par regression non lineaire pour
obtenir la D15o. De l'eau distillee a et filtree et les spectres
d'absorption ont et etablis entre 200 et 350 nm. Les solu-
tions de medicaments (A 2 mg/l) ont et passees au spectro-
photometre avant et apres filtration; la mesure a et effec-
tuee pour chacun des medicaments a la longueur d'onde
optimale soit 343 nm. Les solutions de medicaments (A
2 mg/I) ont e passees au spectrophotometre avant et apres
filtration; la mesure a e effectuee pour chacun des medica-
ments a la longueur d'onde optimale soit 343 nm pour la
chloroquine, 310 nm pour la mefloquine, 340 nm pour
l'amodiaquine et 330 nm pour la quinine. La perte de pro-
duit due a la filtration a ensuite e calculee en pour-
centage.
Une baisse de l'activite antipaludique est apparue apres
filtration sur certains des filtres. Des D150 se sont parfois
montrees 25 fois plus elevees qu'avec les temoins non filtres.
Tous les composes se sont abondamment fixes sur les mem-
branes Millex-GV (67 a 98%). Les solutions filtrees de
chloroquine et de mefloquine A 2000 mg/l ont donne une
D15o comparable a celle des solutions non filtrees; par
contre, une perte d'activite appreciable a et constatee avec
les solutions A 10 mg/l filtrees. En ce qui concerne l'eau
distillee filtree sur unite Millex-GS, on a regulierement
obtenu un pic d'absorption A 277 nm accompagne d'un pic
secondaire A 225 nm; les filtres Nucleopore et Millex-GV
n'ont donne lieu a aucune absorption A 277 nm, tandis
qu'elle etait tres faible avec l'unite de filtration Gelman. La
perte d'activite a donc et attribuee A des fractions extrac-
tibles correspondant A des impuretes contenues dans les
membranes filtrantes et/ou a la fixation du medicament sur
les membranes. Les resultats obtenus montrent en conse-
quence qu'il y a lieu d'interpreter avec circonspection les
etudes de sensibilite in vitro. De meme, il serait souhaitable
que les resultats de l'etude in vitro de la pharmacoresistance
des plasmodies soient accompagnes de la description des
mesures prises pour que la filtration sur membrane des
solutions d'antipaludeens ne contribue pas A reduire leur
activite.
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